Home                  Mission                  Services                  Special Service                  Competencies

 

WELCOME TO

 

KellSa s.a.s.

 

 

Kjell S. Sakariassen, PhD, FAHA

Head of KellSa s.a.s.

Str. Campo e Zampe 12

I-13900 Biella, BI, Italy

 

 

Professional Experience  

 

1984 – 1985:          Post-doctoral ( I )

                               Thrombosis and Atherosclerosis Research Group

                               F. Hoffmann-La Roche Ltd., Basle, Switzerland

                               Head: Professor Hans R. Baumgartner

 

1985 – 1987:          Post-doctoral ( II )

                               Department of Pathology

                               University of Washington, Seattle, WA

                               Head: Professor Russel Ross

 

1987 – 1990:          Research Scientist

                               Preclinical Cardiovascular Research

                               F. Hoffmann-La Roche Ltd., Basle Switzerland

                               Head: Professor Hans R. Baumgartner

 

1990 – 1992:          Group Leader

                               Biotechnology Centre of Oslo

                               University of Oslo, Oslo, Norway

                               Head: Professor Hans Prydz

 

1992 – 1998:          Director of Discovery Research

                               -   Cardiovascular Discovery

                               -   Pharmacology

                               -   Haemostasis Discovery

                               -   Haemostasis and Cardiovascular Diagnostics

                               Nycomed Bioreg, Nycomed Pharma, Nycomed Imaging and

                               Nycomed Amersham Imaging, Oslo, Norway

 

1993 – 1998:          Professor of Physiology

                               Division of Physiology, Department of Biology

                               University of Oslo, Oslo, Norway

 

 

1998 – 2001:            Deputy Director and Director of Pharmacology

                                 -    Endocrine Pharmacology, Uppsala

                                 -    Metabolic Pharmacology, Uppsala

                                 -    Animal Sciences, Uppsala

                                 -    Pharmacology Technologies, Stockholm

                                 -    Transgene and KO Pharmacology, Karolinska Institute, Stockholm

                                 Pharmacia & Upjohn, Pharmacia Corporation and Biovitrum,

                                 Uppsala and Stockholm, Sweden

 

2001 – 2004:            Worldwide Head of Pharmacology and Early Safety Evaluation

-         Early Safety Evaluation, Ivrea

-         Transgene and KO Pharmacology, Ivrea, Geneva and Boston

-         Neuro Pharmacology, Ivrea and Geneva

-         Immuno Pharmacology, Ivrea and Geneva

-         Metabolic Pharmacology, Ivrea, Geneva and Boston

-         Functional Pharmacogenomics, Ivrea

-         Reproductive Pharmacology, Ivrea and Boston

-         Cancer Pharmacology, Ivrea and Boston

                                 Serono Int. S.A., Ivrea, Italy, Geneva, Switzerland, and Boston, MA

 

2004 – Present:       Founder, Owner and Head

                                 Consultation and training of local research teams in novel and unique

                                 technologies

-         Haemostasis

-         Thrombosis

-         Arteriosclerosis

-         Obesity

-         Diabetes

-         Autoimmune / Inflammatory diseases

                                 KellSa s.a.s., Biella, Italy